This lncRNA is abundant in several tumor types, including lung, gastric, and prostate cancers (Cui et al., 2016[9]; Liu et al., 2016[30]; Yuan et al., 2016[45]) and plays oncogenic role via three different mechanisms: interacting with MYC, participating in DNA rearrangements and encoding microRNAs (Cui et al., 2016[10]). The gene discussed is MYC; the disease is Familial prostate cancer.